Title: Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.
Journal: European journal of medicinal chemistry 20130501
Title: Blockade of tachykinin NK3 receptor reverses hypertension through a dopaminergic mechanism in the ventral tegmental area of spontaneously hypertensive rats.
Journal: British journal of pharmacology 20101201
Title: NK-3 receptor antagonism prevents behavioral sensitization to cocaine: a role of glycogen synthase kinase-3 in the nucleus accumbens.
Journal: Journal of neurochemistry 20101101
Title: A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20100223
Title: Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Journal: Nature chemical biology 20091001
Title: Blockade of neurokinin-3 receptors modulates dopamine-mediated behavioral hyperactivity.
Journal: Neuropharmacology 20090901
Title: New quinoline NK3 receptor antagonists with CNS activity.
Journal: Bioorganic & medicinal chemistry letters 20090201
Title: The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils.
Journal: European journal of pharmacology 20081214
Title: cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Journal: Journal of medicinal chemistry 20081127
Title: Localization and function of NK(3) subtype tachykinin receptors of layer V pyramidal neurons of the guinea-pig medial prefrontal cortex.
Journal: Neuroscience 20081028
Title: Cardiovascular responses to intravenous administration of human hemokinin-1 and its truncated form hemokinin-1(4-11) in anesthetized rats.
Journal: European journal of pharmacology 20080820
Title: Neurokinin B/NK3 receptors exert feedback inhibition on L-DOPA actions in the 6-OHDA lesion rat model of Parkinson's disease.
Journal: Neuropharmacology 20080601
Title: Functionalization through lithiation of (S)-N-(1-phenylpropyl)-2-phenylquinoline-4-carboxamide. Application to the labeling with carbon-11 of NK-3 receptor antagonist SB 222200.
Journal: The Journal of organic chemistry 20070316
Title: Neurokinin-3 receptor-specific antagonists talnetant and osanetant show distinct mode of action in cellular Ca2+ mobilization but display similar binding kinetics and identical mechanism of binding in ligand cross-competition.
Journal: Molecular pharmacology 20070301
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Title: Effect of a selective and potent central nervous system penetrant, neurokinin-3 receptor antagonist (SB-222200), on cisplatin-induced emesis in the ferret.
Journal: Neuroscience letters 20050307
Title: Role of neurokinin 3 receptors in supraoptic vasopressin and oxytocin neurons.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20041110
Title: Eledoisin and Kassinin, but not Enterokassinin, stimulate ion transport in frog skin.
Journal: Peptides 20041101
Title: Role of tachykinin receptors in the central processing of afferent input from the acid-threatened rat stomach.
Journal: Regulatory peptides 20011215
Title: Contribution of NK3 tachykinin receptors to propulsion in the rabbit isolated distal colon.
Journal: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20010601
Title: Molecular and pharmacological characterization of the murine tachykinin NK(3) receptor.
Journal: European journal of pharmacology 20010216
Title: Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist.
Journal: The Journal of pharmacology and experimental therapeutics 20001001
Title: 2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptor.
Journal: Journal of medicinal chemistry 19960607
Title: Sarau HM, et al. Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist. J Pharmacol Exp Ther. 2000 Oct;295(1):373-81.
